4166-51-2

Usage

Derived from

Benzoic acid

Contains

Ethylcarbamoyl group

Usage

Synthesis of pharmaceuticals, agrochemicals, and dyes

Potential properties

Anti-inflammatory, anti-cancer

Physical form

White to off-white crystalline powder

Melting point

148-152°C

Solubility in water

6 g/L at 20°C

Safety precautions

Causes skin and eye irritation, harmful if swallowed or inhaled

Upstream product

• 5022-29-7 N-ethylphthalimide 
• 16260-70-1 N-vinyl-phthalamic acid 
• 15025-24-8 2-ethyl-3-hydroxy-1,3-dihydro-2H-isoindol-1-one 
• 3485-84-5 N-vinylphthalimide 

Downstream Products

• 69886-35-7 N-(5-methyl-isoxazol-3-yl)benzamidine 

Relevant academic research and scientific papers

Compounds and methods for inducing chondrogenesis

The present invention provides compounds and compositions for the amelioration of arthritis and joint injuries by inducing mesenchymal stem cells into chondrocytes.

Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them

The application discloses substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics and a medicament comprising them Substituted norbornylamino derivatives having exo-configured nitrogen and an endo-f

11a-Methano-TXA compounds

The present invention provides novel 11a-methano-TXA compounds and intermediates and processs for their preparation. Further provided are methods for using these novel TXA analogs as inhibitors of thromboxane synthetase, rendering these analogs useful for a variety of pharmacological purposes. These pharmacological uses include anti-inflammatory, anti-thromobitc, and anti-asthma indications.